Products

Eko Low Ejection Fraction Tool (ELEFT)
Eko Health
Cardiology AI
The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Eko Foundation Analysis Software with Transformers (EFAST)
Eko Health
Cardiology AI
EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams.

See all 2 products →

About Eko Health

Eko Health is a leading digital health company that is revolutionizing cardiovascular and pulmonary disease detection and monitoring through its innovative portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. For physicians, Eko’s FDA-cleared platform offers enhanced auscultation capabilities, combining amplification and advanced noise cancellation to provide clearer heart and lung sounds, even in challenging clinical environments. This technology aims to overcome the limitations of traditional stethoscopes, enabling more accurate and confident physical exams.

The company’s core offering includes digital stethoscopes like the CORE 500™, which integrates high-fidelity audio, a full-color display with disease indication, and 3-lead ECG. Coupled with the Eko App and the SENSORA® AI software platform, clinicians can leverage FDA-cleared algorithms for the early detection of structural heart murmurs, atrial fibrillation (AFib), and low ejection fraction (a key indicator of heart failure). These AI-powered insights are designed to support clinical decision-making, streamline workflows, and facilitate earlier intervention, ultimately improving patient outcomes.

Beyond in-clinic use, Eko Health’s solutions support telehealth and remote patient monitoring, allowing for secure live streaming of heart and lung sounds and ECG data. This capability is crucial for expanding access to specialized care, managing chronic conditions, and enabling comprehensive physical exams in virtual settings. Eko’s commitment to clinical validation is evident through its evaluation in prominent medical journals and partnerships with leading institutions, reinforcing the reliability and efficacy of its AI-driven diagnostic tools.

Focus Areas

Digital stethoscopes AI software for cardiovascular disease detection AI software for pulmonary disease detection early disease detection remote patient monitoring telehealth auscultation heart murmur detection atrial fibrillation detection low ejection fraction detection

Business Intelligence

Key InvestorsARTIS Ventures, Highland Capital Partners, Questa Capital, NTTVC, DigiTx Partners, Double Point Ventures, EDBI, LG Technology Ventures, Mayo Clinic, Morningside Technology Ventures Limited, 3M Ventures, Founder.org, DreamIt Ventures, 1812 Ventures, Sutter Health
PartnershipsAstellas Pharma, FIGS, Imperial College London, Imperial College Healthcare NHS Trust, Boehringer Ingelheim, Wayne General Hospital, Impilo, The Digital Health Store, 3M Littmann
TechnologySENSORA™ Cardiac Early Detection Platform, AI-powered analysis, digital stethoscopes, patient and provider software, cloud connectivity, machine learning, connected devices, 3-lead ECG
FDA Clearances9 cleared products (estimated)

What Physicians Need to Know

Digital Stethoscopes
Eko Health offers a portfolio of digital stethoscopes, including the COREu2122, DUOu2122 ECG + Digital Stethoscope, 3Mu2122 Littmannu00ae CORE, and CORE 500u2122. These devices provide up to 40x sound amplification and active noise cancellation for enhanced clarity in auscultation. The DUOu2122 and CORE 500u2122 models also integrate a single-lead ECG for simultaneous heart sound and electrical activity capture.
AI Software for Cardiovascular Disease Detection
Eko's FDA-cleared AI algorithms, part of the SENSORAu00ae Cardiac Early Detection Platform, detect structural heart murmurs, atrial fibrillation (AFib), and low ejection fraction (Low EF) within 15 seconds during a routine physical exam. These algorithms are clinically validated and trained on extensive datasets.
AI Software for Pulmonary Disease Detection
Beyond cardiac, Eko's technology supports clear lung auscultation with noise cancellation, aiding in the detection of conditions like pneumonia. An algorithm for the detection of pulmonary hypertension (PH) is also in development and has shown promising results in studies.
Early Disease Detection
Eko's platform is designed for proactive, early disease detection, shifting intervention from late-stage hospitalization to outpatient care. The AI provides instant insights, flagging crucial heart disease indicators in seconds.
Remote Patient Monitoring & Telehealth
The Eko Telehealth platform enables secure, high-fidelity live-streaming of heart and lung sounds, phonocardiograms (PCGs), and ECG waveforms during virtual visits. It is HIPAA and SOC 2 compliant, supporting various virtual care models including hospital-at-home and remote clinics.
Auscultation & Heart/Lung Sound Analysis
Eko enhances traditional auscultation with digital amplification, active noise cancellation, and real-time visualization of heart and lung sounds as waveforms. This allows clinicians to hear and see physiological information with greater clarity and confidence.
Physician Tip

Eko Health's solutions empower physicians by transforming the traditional stethoscope into an AI-powered diagnostic tool. Key differentiators include FDA-cleared AI for heart murmurs, AFib, and low ejection fraction, providing rapid, objective insights within 15 seconds. The digital stethoscopes offer superior sound clarity with amplification and noise cancellation, crucial for accurate assessments in noisy environments. For telehealth, Eko enables high-fidelity remote auscultation and ECG streaming, allowing for comprehensive virtual exams that maintain clinical confidence. The ability to record, save, and share exams facilitates collaboration, tracking patient progress, and seamless documentation within EHRs. This integrated approach streamlines workflows, enhances diagnostic accuracy, and supports earlier intervention, ultimately leading to improved patient outcomes and more confident care decisions.

Eko Health's platform is designed for seamless integration with existing healthcare workflows and systems. It offers robust SDKs and APIs for integration with telehealth solutions and can work alongside existing video conferencing platforms. Crucially, Eko integrates with Electronic Health Records (EHRs), allowing for single sign-on, direct viewing of AI analysis, and automatic pushing of PDF reports or anonymous URLs to the patient's chart, simplifying documentation and providing a comprehensive patient picture.

Products by Eko Health

2 products in the directory

Eko Low Ejection Fraction Tool (ELEFT)
Eko Health
Cardiology AI
The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Eko Foundation Analysis Software with Transformers (EFAST)
Eko Health
Cardiology AI
EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams.

What the Web Says

Eko Health generally receives positive reviews for its digital stethoscopes and AI-powered cardiovascular screening tools, with many users highlighting improved sound quality and the ability to record and share auscultation sounds. However, some users have raised concerns about product durability, customer service, and the company's subscription model for certain app features. As an employer, Eko Health is largely seen as a great place to work, with a positive company culture.

Overall: Positive

Strengths

  • Enhanced sound quality and amplification in digital stethoscopes.
  • AI-powered detection of cardiovascular diseases, improving diagnostic accuracy.
  • Ability to record and visualize heart and lung sounds for review and education.
  • Telehealth integration for remote patient care.
  • Active noise cancellation, especially useful in noisy environments.
  • Positive company culture and a great place to work according to employees.

Limitations

  • Concerns about product durability and earpiece malfunctions.
  • Issues with customer support responsiveness.
  • Subscription model for features previously available for free, leading to extra costs.
  • Data harvesting concerns due to required professional information for app usage.
  • EKG feature may not work well on hairy chests.
  • Stethoscope can be a bit heavy around the neck.

Based on reviews from: Great Place To Work, Eko Health (Official Website), REVIEWS.io, Reddit (r/medicine, r/FamilyMedicine, r/emergencymedicine, r/Paramedics, r/Residency), Becker's Hospital Review, Indeed.com, YouTube (Eko digital stethoscope Gen 1 vs Gen 2 Review and Comparison for Use in Infectious Patients, Eko Core Stethoscope Review with Noise Cancellation), Trustpilot

Last updated: 2026-07-18

Videos

News, demos, and interviews about Eko Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Eko Health →

View all on YouTube

Press & Coverage

Fierce Biotech
Eko Health Raises $41 Million to Scale AI-Driven Heart and Lung Disease Detection
Eko Health secured $41 million in Series D funding to expand its AI-powered stethoscope business globally, following recent FDA clearance for its AI program detecting low cardiac ejection fraction.
2024-06
PR Newswire
AI-Enabled Eko Health Stethoscope TRICORDER Trial Marks Historic Leap in Early Heart Disease Detection
The TRICORDER study, a large randomized evaluation, demonstrated that Eko Health's AI-enabled digital stethoscope significantly increased the detection of heart failure, atrial fibrillation, and valvular heart disease in routine exams.
2025-09
Eko Health
Eko Health Receives First FDA Clearance for Cardiac Foundation Model
Eko Health announced FDA clearance for its EFAST algorithm, the first cardiac foundation model for cardiovascular AI, designed to detect structural heart murmurs and atrial fibrillation with improved specificity and faster exam times.
2025-09
Eko Health
CMS Recognizes Eko Health's AI-Powered Heart Disease Detection in OPPS July 2025 Update, Establishing Payment Rate for SENSORA
The Centers for Medicare & Medicaid Services (CMS) included Eko's SENSORA platform in its July 2025 update, establishing a reimbursement rate for the AI-enabled cardiac detection system.
2025-07
PR Newswire
Large Clinical Study Highlights Eko Health's AI for Early Detection of Pulmonary Hypertension
A peer-reviewed study published in the Journal of the American Heart Association showcased Eko Health's novel algorithm for detecting pulmonary hypertension by analyzing heart sounds recorded with a digital stethoscope.
2025-02
Eko Health
Eko Health Expands into Canada with Launch of CORE 500u2122 Digital Stethoscope and Eko+ Membership
Eko Health launched its CORE 500u2122 Digital Stethoscope and Eko+ membership in Canada, following Health Canada approval, to provide advanced digital auscultation technology to Canadian clinicians.
2025-04
Eko Health
Eko Hits Milestone Number of Stethoscopes Sold
Eko Health announced selling 750,000 digital stethoscopes worldwide, indicating a significant shift from analog to smarter, connected devices for early disease detection.
2026-05
European Heart Journal u2013 Digital Health
Artificial-Intelligence-Enabled Digital Stethoscope Improves Point-of-Care Screening for Moderate-to-Severe Valvular Heart Disease
A study published in the European Heart Journal u2013 Digital Health in February 2026 highlighted how Eko's AI-enabled digital stethoscope improves point-of-care screening for moderate-to-severe valvular heart disease.
2026-02

Frequently Asked Questions

Eko's digital stethoscopes offer advanced audio amplification and noise cancellation, improving sound clarity compared to analog stethoscopes. Their FDA-cleared AI software, integrated with the stethoscopes, analyzes heart sounds and ECG data to detect crucial indicators like heart murmurs, AFib, and low ejection fraction in as little as 15 seconds, providing earlier insights that might be missed in traditional exams.
Eko Health has multiple FDA clearances for its devices and AI algorithms, including for the detection of structural heart murmurs, atrial fibrillation (AFib), and low ejection fraction (Low EF). Their AI for AFib detection boasts 99% sensitivity and 97% specificity, while for Low EF detection, it shows 85% sensitivity and 70% specificity. The EFAST algorithm, an FDA-cleared foundation model, detects structural heart murmurs and AFib with greater specificity and faster exam times.
Eko's technology is telehealth compatible, allowing for stethoscope and ECG live-streaming, often with embedded video conferencing, to facilitate comprehensive virtual cardiac and pulmonary exams. It offers an easily integratable set of SDKs and APIs, supporting encrypted and HIPAA-compliant data transfer, enabling providers to monitor patients remotely and expand access to specialty care, especially in rural areas.
While specific enterprise pricing models are not publicly detailed, Eko states that its advanced stethoscope technology costs around $2.00 a day for individual clinicians. The potential ROI for healthcare systems comes from earlier disease detection, which can reduce diagnostic bottlenecks, expedite access to life-extending treatments, prevent hospitalizations, and ultimately lower healthcare costs. CMS has also established a payment rate for Eko's SENSORA platform, creating a financial pathway for implementation.
Eko Health provides a Help Center with user manuals and FAQs, offers live demos and Q&A sessions, and has a sales team available for consultations on enterprise solutions. They also offer the Eko Academy, a free educational mobile app designed to strengthen auscultation skills and knowledge for medical students and seasoned healthcare providers, including high-fidelity heart and lung recordings.
Eko Health is a leading digital health company with over 500,000 healthcare professionals worldwide using its FDA-cleared platform. They recently raised $41 million in Series D financing to expand U.S. and global access. Their long-term vision is to revolutionize healthcare through early detection and high-quality care, leveraging AI to unlock universal access to expert-level cardiac and pulmonary disease detection, aiming to transform the stethoscope into a powerful early disease detection platform.
Eko Health prioritizes data security and maintains HIPAA-compliant policies, procedures, and technical safeguards for patient and customer data. They utilize HIPAA-compliant and NIST-recommended 256-bit AES encryption for patient data, conduct nightly encrypted backups, and are SOC 2 certified, ensuring secure facilities and adherence to Business Associate Agreements (BAAs) with subcontractors.

Investors

Who's funded Eko Health.

Tomorrow Capital
VC T2
Mumbai, India
$1M-$5M
Tomorrow Capital is a Mumbai-based early-stage operational VC with a clear focus on tech-enabled healthcare delivery and consumer wellness brands, writing checks…
Care Delivery / Tech-Enabled Services Wellness / Consumer Health
Lightbox Ventures
VC T2
Mumbai, India
$5M-$25M
Lightbox Ventures is a Mumbai-based venture capital firm with a multi-vintage record of backing consumer technology and wellness platforms in India. Check…
Digital Health Wellness / Consumer Health
EDBI
Corporate VC AI T2
Singapore, Singapore
$5M-$25M
EDBI is the strategic investment arm of the Singapore Economic Development Board, headquartered in Singapore with a global mandate and a long…
AI/ML in Healthcare Biotech
Pegasus Capital
PE T3
Dublin, Ireland
$5M-$25M
Pegasus Capital is a Dublin-based corporate finance and private equity advisory firm that executes high-value domestic health sector transactions across Ireland. The…
Care Delivery / Tech-Enabled Services
Sutter Health Ventures
Corporate VC T3
Sacramento, United States
$1M-$5M
Sutter Health Ventures is the strategic venture entity of Sutter Health, a major California-based health system headquartered in Sacramento. The fund backs…
Care Delivery / Tech-Enabled Services Digital Health
ah! Ventures
Angel Network T3
Mumbai, India
<$250k
ah! Ventures is one of India’s earliest organized angel networks and a multi-stage early-stage investor backing founders across consumer, fintech, SaaS, healthcare,…
Digital Health MedTech
Wildwood Ventures
VC T3
Denver, United States
$250k-$1M
Wildwood Ventures, at wildwood.vc with LinkedIn and Crunchbase profiles, is an early-stage venture firm without disclosed stage, sector, or check size in…
AI/ML in Healthcare Digital Health
Ulu Ventures
VC T3
Palo Alto, United States
$1M-$5M
Ulu Ventures is a Bay Area early-stage firm at uluventures.com with a Crunchbase profile and active LinkedIn presence, known for a disciplined…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Target Global
VC T3
Berlin, Germany
$1M-$5M
Target Global is a European multi-stage technology investment firm with offices in Berlin, London, and other locations, investing across software, marketplaces, financial…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Lifeforce Capital
VC T3
San Francisco, United States
$250k-$1M
Lifeforce Capital presents as an early-stage venture investor with a thesis tilt toward longevity, performance health, and consumer biology, though detailed public…
AI/ML in Healthcare Biotech
Keiretsu Forum Spain
Angel Network T3
Barcelona, Spain
$250k-$1M
Keiretsu Forum Spain is the Spanish chapter of the global Keiretsu Forum angel investment network, comprised of accredited angel investors who collectively…
Biotech Diagnostics

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.